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Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma
Activation of telomerase is crucial for the continued growth and progression of cancer cells. Because retinoic acid (RA) plays an important role in
the growth and differentiation of keratinocytes and since RA has some preventive and therapeutic effects on human skin cancers, Kunisada et al.
examined the effect of RA on telomerase activity of HSC-1 human cutaneous squamous cell carcinoma cells. From this study, treatment of HSC-1
cells with all-trans RA signiﬁcantly suppressed their telomerase activity and phosphorylation of ERK and AKT. They indicate that RA is effective in
inhibiting telomerase activity in HSC-1 cells and suppression of ERK and AKT activation is presumed to be involved in this inhibitory pathway.
Kunisada M, Budiyanto A, Bito T et al. Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma. Br J
Dermatol 2005; 152:435–443.
Longer term reassurance for the Ukrainian President, Viktor Yushchenko
This study, undertaken nearly 20 years after the July 1976 Seveso, dioxin poisoning industrial accident looked for long-term medical effects of its
action. Plasma dioxin was strongly associated with chloracne, characterized by pale-yellow keratin cysts and larger and prominent comedones.
Though several medical conditions have been reported in such chloracne cases, in this study their frequency and type did not signiﬁcantly differ
over controls.
The latter will give some comfort to the recently elected Ukrainian Presidential candidate, Viktor Yushchenko, who on 5 September 2004, fell ill
after having dinner with Ukrainian Security Services. Despite developing bad chloracne, his long-term health may be better prognosis than was
earlier speculated.
Baccarelli A, Pesatori AC, Consonni D et al. Health status dioxin levels in chloracne cases 20 years after the Seveso, Italy accident. Br J Dermatol
2005; 152:459–465.
Predictions of skin cancer incidence in the Netherlands
up to 2015
Skin cancer is a growing clinical and public health problem, placing a
heavy burden on dermatologists and general practitioners. Between
2000 and 2015, an 80% increase in the number of incident skin
cancers is expected in the Netherlands, due to further increases in
incidence rates and demographic changes. Strong increases in
incidence rates of basal cell carcinoma (BCC) and melanoma are
expected, also in young age groups. BCC is expected to increase on
the trunk and limbs and to stabilise in the head and neck region.
Without changes in current exposure, increases in skin cancer will
continue after 2015.
de Vries E, Van de Poll-Franse LV, Louwman WJ et al. Predictions
of skin cancer incidence in the Netherlands up to 2015. Br J
Dermatol 2005; 152:481–488.
Clinicopathological features of cutaneous lesions of adult T-cell
leukaemia ⁄ lymphoma
Adult T-cell leukaemia ⁄ lymphoma is associated with human T-cell leukaemia virus type I
(HTLV-I) can be diagnosed based on clinicopathological ﬁndings and the presence of
monoclonal integrated HTLV-I provirus in the DNA of tumour cells. The cutaneous
lesions in 80 patients with serum anti-ATL antibody, to clarify the correlation between
macroscopic ⁄ histopathological ﬁndings and prognosis. The median survival time of
patients with monoclonal proviral DNA integration in cutaneous lesions was 14 months,
which was markedly shorter than that of patients negative for proviral DNA integration
(72 months). Patients with papules and nodules had poorer prognosis than those with
erythema. Histopathologically, the prognosis was poorer in patients with nodular or
diffuse inﬁltration of medium-sized to large lymphoma cells, compared with those with
perivascular inﬁltration of small to medium-sized lymphoma cells.
Yamaguchi T, Ohshima K, Karube K et al. Clinicopathological features of cutaneous
lesions of adult T-cell leukaemia ⁄ lymphoma. Br J Dermatol 2005; 152:76–81.
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